electroCore awards director 11,123 stock units

electroCore, Inc. (symbol: ECOR) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Filing Summary

electroCore, Inc. (symbol: ECOR) is the issuer of record for a Form 4 filing submitted to the SEC. Goldstein Julie Ann reported acquisition or exercise transactions in this Form 4 filing.

electroCore, Inc. (ECOR) director Julie Ann Goldstein reported an equity compensation grant of 11,123 shares of Common Stock in the form of Annual Deferred Stock Units on September 9, 2026, at a stated price of $0.00 per share, with no Rule 10b5-1 trading plan reported.

The Deferred Stock Units vest in 12 equal monthly installments from the grant date, or earlier in full before the next annual stockholder meeting or immediately prior to a change of control, subject to continuous service. Following this award, her reported holdings total 112,510 shares, including 29,011 vested Deferred Stock Units and 1,665 shares held through NeuroSpine Ventures, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.

Insider Trade Summary

Grant/Award: 11,123 shares

Grant/Award 1 txn

Insider Goldstein Julie Ann

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2, F3	11,123	$0.00	$0.00

Holdings After Transaction: Common Stock — 112,510 shares (Direct)

Footnotes (3)

1. F1. Annual Deferred Stock Units award which vests in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting following the grant date, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person (RP) remains in continuous service with the Issuer or an affiliate through the applicable vesting date.
2. F2. Includes 29,011 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested shares were previously reported on Form 4 filings at the time of grant.
3. F3. Includes 1,665 shares held in NeuroSpine Ventures; an entity in which the RP has no voting or dispositive power over the shares. Accordingly, the RP disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.

Key Figures

Deferred Stock Units granted: 11,123 shares Grant price: $0.00 per share Total holdings after transaction: 112,510 shares +3 more

6 metrics

Deferred Stock Units granted 11,123 shares Annual Deferred Stock Units award to director on September 9, 2026

Grant price $0.00 per share Stated price for the Deferred Stock Units award

Total holdings after transaction 112,510 shares Total Common Stock reported as owned following the grant

Previously vested Deferred Stock Units 29,011 shares Shares vested from prior Deferred Stock Units awards

Indirect NeuroSpine Ventures holdings 1,665 shares Shares held by NeuroSpine Ventures, with beneficial ownership disclaimed except for pecuniary interest

Vesting schedule tranches 12 installments Number of equal monthly vesting installments from grant date

Key Terms

Deferred Stock Units, change of control, beneficial ownership, pecuniary interest

4 terms

Deferred Stock Units financial

"Annual Deferred Stock Units award which vests in 12 equal monthly installments"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

change of control financial

"immediately prior to a change of control, in each case, provided that"

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

beneficial ownership financial

"disclaims beneficial ownership of these securities except to the extent"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of her pecuniary interest therein, and the inclusion"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ECOR director Julie Ann Goldstein report?

She reported an award of 11,123 shares of electroCore, Inc. Common Stock in the form of Annual Deferred Stock Units on September 9, 2026, at a stated price of $0.00 per share, characterized as a grant or other acquisition of securities.

How do the new Deferred Stock Units for ECOR vest?

The Annual Deferred Stock Units vest in 12 equal monthly installments from the grant date, or will vest in full on the earlier of one business day prior to electroCore’s next annual stockholder meeting or immediately prior to a change of control, provided she remains in continuous service.

What are Julie Ann Goldstein’s total reported ECOR holdings after this Form 4?

After the reported award, her holdings total 112,510 shares of electroCore Common Stock, which include 29,011 shares vested from previously issued Deferred Stock Units and 1,665 shares held via NeuroSpine Ventures, where she disclaims full beneficial ownership.

Does the ECOR filing state that the grant was under a Rule 10b5-1 plan?

No. The filing indicates no Rule 10b5-1 trading plan is reported for this transaction, meaning the award is described simply as an equity grant rather than a trade executed under a pre-arranged trading plan.

What does the footnote say about the ECOR shares held in NeuroSpine Ventures?

The footnote states that 1,665 shares are held in NeuroSpine Ventures, an entity where she has no voting or dispositive power. She disclaims beneficial ownership of these securities except to the extent of her pecuniary interest in the entity.

How many ECOR shares from prior Deferred Stock Units have already vested for Julie Ann Goldstein?

The filing specifies that her holdings include 29,011 shares that have vested under previously issued Deferred Stock Units. These vested shares were reported earlier at the time of their original grants on prior Forms 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:06 PM Accepted by SEC EDGAR 09/10/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldstein Julie Ann

(Last) (First) (Middle)

200 FORGE WAY,

SUITE 205

(Street)

ROCKAWAY NEW JERSEY 07866

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
electroCore, Inc. [ ECOR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2026		A		11,123(1)	A	$0.00	112,510(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual Deferred Stock Units award which vests in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting following the grant date, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person (RP) remains in continuous service with the Issuer or an affiliate through the applicable vesting date.

2. Includes 29,011 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested shares were previously reported on Form 4 filings at the time of grant.

3. Includes 1,665 shares held in NeuroSpine Ventures; an entity in which the RP has no voting or dispositive power over the shares. Accordingly, the RP disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.

	/s/ John L. Cleary, II, attorney-in-fact	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)